Lockie SH, Heppner KM, Chaudhary N, Chabenne JR, Morgan DA, Veyrat-Durebex C, et al
Retatrutide is now attracting attention because it is being studied as a triple-receptor medication that activates GLP-1, GIP, and glucagon pathways
A Mounjaro, which uses the same ingredient (tirzepatide) and is made by the same company (Eli Lilly), is for people with diabetes
Noom, an online weight loss company, will now be selling small doses of compounded versions of Wegovy, the prescription medication developed by Novo Nordisk
Contact us today to learn more!